. "Appendix F: Prospects for Immunizing Against Hemophilus influenzae type b." New Vaccine Development: Establishing Priorities: Volume I, Diseases of Importance in the United States. Washington, DC: The National Academies Press, 1985.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
New Vaccine Development Establishing Priorities, Volume I: Diseases of Importance in the United States
PROSPECTS FOR IMMUNIZING AGAINST HEMOPHILUSINFLUENZAE TYPE b
Hemophilusinfluenzae type b is a major cause of meningitis in young children. Neurological sequelae, including hearing and vision loss, motor abnormalities, seizure disorders, severe mental retardation, and quadriplegia, may follow the meningitis (Norden, 1982). The case-fatality ratio is approximately 5 percent with adequate treatment, and almost 90 percent without proper care. Other invasive forms of the disease include epiglottiditis, pneumonia, bacteremia, and cellulitis.
Studies indicate that H.influenzae first colonizes the nasopharynx and then penetrates the mucosa. Capsulated H.influenzae strains are responsible for most severe illness, although non-capsulated strains occasionally have been associated with infection. Of the six encapsulated strains, type b is by far the most common cause of invasive disease (Norden, 1982). Host intervention through the production of anticapsular antibodies can prevent disease.
The mechanism by which virulent H.influenzae organisms gain access to the blood is not known, but a bacteremic phase that is generally asymptomatic precedes invasion of the meninges. Whether the organism will go on to cause meningitis depends on its virulence and the immune status of the host. Invasion of the cerebrospinal fluid is followed by the usual symptoms of bacterial meningitis, which if not treated promptly is often fatal.
Nonencapsulated H.influenzae strains, although common, are largely avirulent. There are six serotypes of H.influenzae with immunochemically distinct capsular polysaccharides (Egan et al., 1982). They are identified as types a, b, c, d, e, and f. Almost all invasive H.influenzae disease is caused by type b (Norden, 1982). Thus, a vaccination program can be directed against a single type.
The advice and assistance of C.V.Broome, S.L.Cochi, C.Frasch, D.M. Granoff, A.L.Reingold, and J.Ward in the preparation of this appendix is gratefully acknowledged. The committee assumes full responsibility for any judgments or assumptions.
Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole. Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.